Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes

被引:28
|
作者
Skovso, S. [1 ]
Damgaard, J. [2 ]
Fels, J. J. [2 ]
Olsen, G. S. [2 ]
Wolf, X. A. [2 ]
Rolin, B. [2 ]
Holst, J. J. [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Endocrinol Res Sect, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
[2] Novo Nordisk A S, Diabet Res Unit, Malov, Denmark
关键词
BODY-FAT; ADIPOSE-TISSUE; RISK-FACTOR; NPH INSULIN; OBESITY; RECEPTOR; PARTICIPANTS; ADIPONECTIN; DETERMINANT; CHOLESTEROL;
D O I
10.1038/ijo.2015.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND/OBJECTIVES: Insulin therapy is required for many patients with the obesity-related disorder type 2 diabetes, but is also associated with weight gain. The specific location of adipose tissue location matters to cardiovascular disease (CVD) risk. We investigated effects of exogenous insulin on fat distribution in the high-fat/high-sucrose fed rat treated with streptozotocin (HF/HS-STZ) rat model of type 2 diabetes. We also examined effects of insulin therapy on circulating CVD markers, including adiponectin, triglycerides (TGs), total cholesterol and high-density lipoprotein. SUBJECTS/METHODS: Male SD rats were HF/HS fed for 5 weeks followed by STZ treatment to mimic the hallmarks of human obesity-associated insulin resistance followed by hyperglycemia. Magnetic resonance imaging and computed tomography were used to determine total fat, abdominal fat distribution and liver fat before and after insulin therapy in HF/HS-STZ rats. HbA1c%, TGs, cholesterol, high-density lipoprotein and adiponectin were analyzed by conventional methods adapted for rats. RESULTS: Insulin therapy lowered HbA1c (P<0.001), increased body weight (P<0.001), increased lean mass (P<0.001) and led to a near doubling of total fat mass (P<0.001), with the highest increase in subcutaneous adipose tissue as compared with visceral adipose tissue (P<0.001). No changes in liver fat were observed after insulin therapy, whereas plasma TG and cholesterol levels were decreased (P<0.001, P<0.01), while high-density lipoprotein (HDL) and adiponectin levels were elevated (P<0.01, P<0.001). CONCLUSIONS: Using the HF/HS-STZ rat as an animal model for type 2 diabetes, we find that insulin therapy modulates fat distribution. Specifically, our data show that insulin has a relatively positive effect on CVD-associated parameters, including abdominal fat distribution, lean body mass, adiponectin, TGs and HDL in HF/HS-STZ rats, despite a modest gain in weight.
引用
收藏
页码:1531 / 1538
页数:8
相关论文
共 50 条
  • [1] Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes
    S Skovsø
    J Damgaard
    J J Fels
    G S Olsen
    X A Wolf
    B Rolin
    J J Holst
    International Journal of Obesity, 2015, 39 : 1531 - 1538
  • [2] Weight gain and fat distribution with pioglitazone in patients with type 2 diabetes on insulin therapy.
    Shah, P. K.
    Mudahar, S.
    Aroda, V.
    Wilson, J.
    Chao, E.
    Chang, A.
    Skouse, J.
    Burke, P.
    Andre, M.
    Henry, R. R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S95 - S95
  • [3] Effects of pioglitazone and insulin versus insulin therapy alone on weight gain and fat distribution in obese patients with type 2 diabetes
    Shah, Priya
    Mudaliar, Sunder
    Aroda, Vanita
    Wilson, Janet
    Andre, Michael
    Chao, Edward
    Kouse, Jennifer
    Burke, Paivi
    Henry, Robert
    DIABETES, 2008, 57 : A142 - A142
  • [4] Insulin Therapy and Type 2 Diabetes: Management of Weight Gain
    McFarlane, Samy I.
    JOURNAL OF CLINICAL HYPERTENSION, 2009, 11 (10): : 601 - 607
  • [5] Insulin therapy in type 2 diabetes and weight gain in the short term
    Hmida, C.
    DIABETES & METABOLISM, 2009, 35 : A67 - A68
  • [6] Weight gain during insulin therapy in patients with type 2 diabetes mellitus
    Heller, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 65 : S23 - S27
  • [7] Insulin therapy does not itself induce weight gain in patients with type 2 diabetes
    Larger, E
    Rufat, P
    Dubois-Laforgue, D
    Ledoux, S
    DIABETES CARE, 2001, 24 (10) : 1849 - 1850
  • [8] Insulin treatment and the problem of weight gain in type 2 diabetes
    Carver, Catherine
    DIABETES EDUCATOR, 2006, 32 (06): : 910 - 917
  • [9] Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
    Shah, P. K.
    Mudaliar, S.
    Chang, A. R.
    Aroda, V.
    Andre, M.
    Burke, P.
    Henry, R. R.
    DIABETES OBESITY & METABOLISM, 2011, 13 (06): : 505 - 510
  • [10] The research on the effects of APS increased insulin sensitivity and reduced ER stress in a STZ induced rat model of type 2 diabetes
    Wang, Nian
    Ouyang, Jingping
    Zou, Feng
    Zhang, Deling
    Wu, Dehong
    FASEB JOURNAL, 2008, 22